DANIEL G WELCH Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DANIEL G WELCH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DANIEL G WELCH. DANIEL G WELCH is a CEO and President in INTERMUNE INC ($ITMN) and a Chairman, CEO and President in INTERMUNE INC ($ITMN) and a President & CEO in INTERMUNE INC ($ITMN) and a President and CEO in INTERMUNE INC ($ITMN) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a Director in HYPERION THERAPEUTICS INC ($HPTX) and a in Ultragenyx Pharmaceutical Inc. ($RARE) and a Director in Ultragenyx Pharmaceutical Inc. ($RARE) and a Director in AveXis, Inc. ($AVXS) and a Director in Nuvation Bio Inc. ($PANA).

Address: 3280 BAYSHORE BOULEVARD BRISBANE 94005 CA

Companies in which DANIEL G WELCH is an Insider

AveXis, Inc.

Trading Symbol: AVXS
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL G WELCH: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2018
$AVXS Market Capitalization: $1.59B
$AVXS Previous Close: $58.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

HYPERION THERAPEUTICS INC

Trading Symbol: HPTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL G WELCH: Director
Holdings: 0 shares
Latest Transaction: May 08 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL G WELCH: Director
Holdings: 8,060 shares
Current Value: $915,374
Latest Transaction: Jun 01 2020
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

INTERMUNE INC

Trading Symbol: ITMN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL G WELCH: Chairman, CEO and President, CEO and President, President & CEO, President and CEO
Holdings: 98,106 shares
Latest Transaction: May 07 2014

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Nuvation Bio Inc.

Trading Symbol: NUVB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL G WELCH: Director
Holdings: 0 shares
Latest Transaction: Feb 12 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL G WELCH: Director
Holdings: 65,348 shares
Current Value: $3,972,505
Latest Transaction: Nov 04 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ultragenyx Pharmaceutical Inc.

Trading Symbol: RARE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL G WELCH: Director
Holdings: 12,300 shares
Current Value: $896,793
Latest Transaction: Jun 30 2020
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of DANIEL G WELCH

Sentiment: All, AVXS, HPTX, ICPT, ITMN, NUVB, SGEN, RARE

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 12 2021PANANuvation Bio Inc.WELCH DANIEL GDirectorOption ExerciseA1.74312,750544,185312,750
Feb 12 2021PANANuvation Bio Inc.WELCH DANIEL GDirectorOption ExerciseA4.6086,184396,44686,184
Nov 04 2020SGENSeagen Inc.WELCH DANIEL GDirectorOption ExerciseM36.708,750321,1250
Nov 04 2020SGENSeagen Inc.WELCH DANIEL GDirectorOption ExerciseM34.258,750299,6880
Nov 04 2020SGENSeagen Inc.WELCH DANIEL GDirectorOption ExerciseM20.069,518190,9310
Nov 04 2020SGENSeagen Inc.WELCH DANIEL GDirectorOption ExerciseM20.067,982160,1199,518
Nov 04 2020SGENSeagen Inc.WELCH DANIEL GDirectorOption ExerciseM19.0214,500275,7900

View all DANIEL G WELCH insider transactions.

What is the IPO and How Does a Company Go Public?

IPO stands for Initial Public Offering. An IPO is done when a privately owned company wants to sell a portion of it to public investors. Through this process the company is transformed from a privately owned to a company owned by public investors. More ...

How Companies Report Insider Transactions

Trading of stock is controlled by the Securities and Exchange Commission (SEC), an agency of the United States federal government. More ...

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

Contact us | Follow us on Twitter